Table I.
NCI-H1299 | Balb/3T3 with BB2R | Balb/3T3 with BB1R | Balb/3T3 with BRS-3 | |
---|---|---|---|---|
Peptide | IC50, nM | |||
BA2 | 6 ± 1 | 0.6 ± 0.1 | 12 ± 1 | 14 ± 2 |
Dol-LC-BA1 | 150 ± 18 | 21 ± 2 | 270 ± 30 | 370 ± 60 |
Dols-LD-BA1 | 20 ± 2 | 4 ± 1 | 190 ± 30 | 380 ± 40 |
Dols-LE-BA1 | 15 ± 1 | 18 ± 2 | 1120 ± 90 | 1420 ± 130 |
Hem-LA-BA1 | 15 ± 2 | 8 ± 1 | 130 ± 10 | 540 ± 50 |
Hem-LB-BA1 | 25 ± 3 | 5 ± 1 | 69 ± 9 | 160 ± 30 |
The mean value ± S.D. of 3 determinations each repeated in quadruplicate is indicated. (125I-Tyr4)BB was bound to NCI-H1299 cells for 20 min at 37°C. 125I-BA2 was bound to Balb/3T3 cells for 60 min at 25°C. The structures of the peptides are shown below:
BA1 DPhe-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2
BA2 DTyr-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2